PHILADELPHIA CHROMOSOME POSITIVE
Clinical trials for PHILADELPHIA CHROMOSOME POSITIVE explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA CHROMOSOME POSITIVE trials appear
Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shielding hearts from Chemo's toxic blow in blood cancer battle
Disease control Recruiting nowThis study is testing whether a drug called dexrazoxane can protect the heart from damage caused by powerful chemotherapy used to treat aggressive blood cancers like acute myeloid leukemia. It will enroll 100 patients with these cancers who are receiving a specific combination of…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Two-Pronged attack on tough leukemia shows promise
Disease control Recruiting nowThis study is testing whether combining two drugs, blinatumomab and asciminib, can help control a fast-growing blood cancer called Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). It will involve about 40 adults and teenagers, including those newly diagnosed and thos…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New combo pill aims for deep remission in blood cancer, hoping patients can stop treatment
Disease control Recruiting nowThis study is testing whether adding a pill called ASTX727 to the standard drug dasatinib works better for people newly diagnosed with a slow-growing type of blood cancer called chronic myeloid leukemia (CML). The goal is to achieve a very deep remission, where the cancer is near…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
New combo attack on tough leukemia shows promise
Disease control Recruiting nowThis study is testing a new combination of drugs for adults with a specific, aggressive type of leukemia (Philadelphia chromosome-positive ALL) that has come back or hasn't responded to other treatments. The treatment combines an immunotherapy drug that helps the immune system fi…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC